Dr. Bickel joined the department in 1999. He received his education from the Medical School at University of Ulm (Germany) and was awarded the Doctor of Medicine degree (1985). Completing a residency at Benjamin Franklin University Clinic (Berlin, Germany) he was board certified in Clinical Pharmacology (1991). Dr. Bickel then focused on blood-brain barrier research, working with Dr. William M. Pardridge (Department of Medicine, University of California, Los Angeles) as a Visiting Scientist on a stipend from the German Research Foundation (1991-1994) and in his own lab at Philipps-University, Marburg (1994-1999). Dr. Bickel has been regularly invited to present at international meetings including Gordon Research Conferences. At Texas Tech, his lab has been supported by grants from the National Institute of Neurological Disorders and Stroke, the National Multiple Sclerosis Society, the American Heart Association, and the DoD Breast Cancer Research Program. He served on NIH study sections and is a reviewer for various pharmacological and pharmaceutical journals.
Languages
- German
Interests
- Breast health/cancer
- Pharmacology
- Stroke
Pharmacy Research Interests
- Breast Cancer
- NFkB
- blood-brain barrier (BBB)
- brain drug transport
- brain tumor
- clinical pharmacology
- drug delivery
- drug transport
- endothelial cells
- liposomes
- macromolecules
- monoclonal antibodies
- nanoparticles
- neuroinflammation
- oligonucleotide-based drubs
- permeability
- pharmacokinetics